]>
IRCT20180627040253N1 IRCT 2018-07-02 Mashhad University of Medical Sciences The effect of vitamin C on type 2 diabetes patient. A clinical trial to compare the effectiveness of vitamin C with placebo on fast blood sugar and hemoglobin A1C levels on type 2 diabetes patient. 2018-10-02 anticipated 54 Complete https://irct.ir/trial/32210 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: 54 patients whose type 2 diabetes and visited at diabetes Clinic of Imam Reza Hospital were chosen randomly based on random numbers table is compiled by computers that regulate the numbers randomly, and assigned to control and intervention groups. A code was allocated to each of the participants, Blinding description: Patients with type 2 diabetes and visited at diabetes Clinic of Department of Imam Reza Hospital, are chosen as the participants of the study. In this double-blind study, the participants and responsible for data collection are unaware of type of drug. 2 Type 2 diabetes. Intervention 1: Control group: who are revising 4 tablets of 250 mg of placebo (Having same color of vitamin C tablets without any active ingredient) per day for 3 months. Fast blood sugar (FBS), hemoglobin A1C (HbA1C), Cholesterol, triglyceride (TG), HDL and LDL levels will be measured by laboratory experiment before, and 3 months after intervention. Intervention 2: Intervention group: who are revising 4 tablets of 250 mg of vitamin C (Producing by Iranian pharmaceutical company) per day for 3 months. Fast blood sugar (FBS), hemoglobin A1C (HbA1C), Cholesterol, triglyceride (TG), HDL and LDL levels will be measured by laboratory experiment before, and 3 months after intervention. Yes - There is a plan to make this available What will be shared: The total data to be included are the primary and secondary effects to be shared. When: 6 months after printing results To whom: Our data will only be available to researchers working in science center and university. Under which criteria data/document could be used Conditions: Our data will be available for scholars working in science center and university. Where to obtain: Behzad Razavi provides the analysis code to the applicants via email: razavib@mums.ac.ir How to obtain: Data collection was done for 10 months, data were collected one month, statistical analysis of one month, information dissemination as a article six months. Comments:
public Behzad Razavi
Imam Reza Hospital, Ibn Sina Avenue, Imam Reza Square
Mashhad Iran (Islamic Republic of) 9137913316 +98 51 3802 2000 razavib@mums.ac.ir Mashhad University of Medical Sciences scientific Behzad Razavi
Imam Reza Hospital, Ibn Sina Avenue, Imam Reza Square
Mashhad Iran (Islamic Republic of) 9137913316 +98 51 3802 2000 razavib@mums.ac.ir Mashhad University of Medical Sciences Iran (Islamic Republic of) Patients with type 2 diabetes who receive only oral diabetes treatment that have not changed their treatment for last three months Having HbA1c less than 8 no limit no limit Both Having kidney stones, , , , GFR less than 60 Having gestational diabetes Insulin-treated patients pregnant women E11 Type 2 diabetes mellitus Treatment - Drugs Treatment - Drugs Control group: who are revising 4 tablets of 250 mg of placebo (Having same color of vitamin C tablets without any active ingredient) per day for 3 months. Fast blood sugar (FBS), hemoglobin A1C (HbA1C), Cholesterol, triglyceride (TG), HDL and LDL levels will be measured by laboratory experiment before, and 3 months after intervention. Intervention group: who are revising 4 tablets of 250 mg of vitamin C (Producing by Iranian pharmaceutical company) per day for 3 months. Fast blood sugar (FBS), hemoglobin A1C (HbA1C), Cholesterol, triglyceride (TG), HDL and LDL levels will be measured by laboratory experiment before, and 3 months after intervention. The amount of fast blood sugar (FBS), hemoglobin A1C (HbA1C), Cholesterol, triglyceride (TG), HDL and LDL levels. Timepoint: before, and 3 months after intervention. Method of measurement: Laboratory experiment. Mashhad University of Medical Sciences Approved 2018-04-30 Ethics Committee of Mashhad University of Medical Sciences Vice Chancellor for Research, Mashhad University of Medical Sciences, Ghoreishi building, Daneshgah Street Mashhad Razavi Khorasan Iran (Islamic Republic of)